Effects of histamine H1 receptor antagonists on depressive-like behavior in diabetic mice

Pharmacology Biochemistry and Behavior

Volumn 83, Issue 2, 2006, Pages 214-220

  Hirano, Shoko ^a   Miyata, Shigeo ^a   Onodera, Kenji ^b   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cetirizine; Chlorpheniramine; Depressive like behavior; Diabetes; Epinastine; Histamine H1 receptor; Tail suspension test

Indexed keywords

CETIRIZINE; CHLORPHENIRAMINE; EPINASTINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DOSE RESPONSE; DRUG SELECTIVITY; FRONTAL CORTEX; HYPOTHALAMUS; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; STATISTICAL SIGNIFICANCE;

ANIMALS; CETIRIZINE; DEPRESSION; DIBENZAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HYPOTHALAMUS; IMIDAZOLES; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY;

ANIMALIA;

EID: 33646071813     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.02.001     Document Type: Article

References (54)

1. Anderson R.J., Freedland K.E., Clouse R.E., and Lustman P.J. The prevalence of comorbid depression in adults with diabetes. A meta-analysis. Diabetes Care 24 (2001) 1069-1078
2. Aoki T., Narita M., Ohnishi O., Mizuo K., Narita M., Yajima Y., et al. Disruption of the type 1 inositol 1,4,5-trisphosphate receptor gene suppresses the morphine-induced antinociception in the mouse. Neurosci Lett 350 (2003) 69-72
3. Arison R.N., Ciaccio E.I., Glitzer M.S., Cassaro J.A., and Pruss M.P. Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin. Diabetes 16 (1967) 51-56
4. Biessels G.J., Kappelle A.C., Bravenboer B., Erkelens D.W., and Gispen W.H. Cerebral function in diabetes mellitus. Diabetologia 37 (1994) 643-650
5. Bugajski A.J., Chlap Z., Gadek-Michalska, and Bugajski J. Effect of isolation stress on brain mast cells and brain histamine levels in rats. Agents Actions 41 (1994) C75-C76
6. Chishty M., Reichel A., Siva J., Abbott N.J., and Begley D.J. Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines. J Drug Target 9 (2001) 223-228
7. de Groot M., Anderson R., Freedland K.E., Clouse R.E., and Lustman P.J. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63 (2001) 619-630
8. Fugner A., Bechtel W.D., Kuhn F.J., and Mierau J. In vitro and in vivo studies of the non-sedating antihistamine epinastine. Arzneimittelforschung 38 (1988) 1446-1453
9. Gill D.S., Thompson C.S., and Dandona P. Increased histamine in plasma and tissues diabetic rats. Diabetes Res 7 (1988) 31-34
10. Gulat-Marnay C., Lafitte A., Arrang J.M., and Schwartz J.C. Modulation of histamine release and synthesis in the brain mediated by alpha 2-adrenoceptors. J Neurochem 53 (1989) 513-518
11. Hilakivi-Clarke L.A., Wozniak K.M., Durcan M.J., and Linnoila M. Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression. Physiol Behav 48 (1990) 429-433
12. Hill S.J., and Straw R.M. Alpha 2-adrenoceptor-mediated inhibition of histamine release from rat cerebral cortical slices. Br J Pharmacol 95 (1988) 1213-1219
13. Hohenegger M., and Rudas B. Kidney function in experimental diabetic ketosis. Diabetologia 7 (1971) 334-338
14. Ito C., Shen H., Toyota H., Kubota Y., Sakurai E., Watanabe T., et al. Effects of the acute and chronic restraint stresses on the central histaminergic neuron system of Fischer rat. Neurosci Lett 262 (1999) 143-145
15. Kamei J., Miyata S., Morita K., Saitoh A., and Takeda H. Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice. Pharmacol Biochem Behav 75 (2003) 247-254
16. 1-receptor antagonists on the pentobarbital-induced loss of the righting reflex in streptozotocin-induced diabetic mice. J Pharmacol Sci 97 (2005) 266-272
17. 1 receptor binding in the brain of depressed patients. Eur J Neurosci 20 (2004) 803-810
18. 14C] streptozotocin and its distribution and excretion in the rat. Biochem J 142 (1974) 673-683
19. Kato M., Nishida A., Aga Y., Kita J., Kudo Y., Narita H., et al. Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent betotastine besilate. Arzneimittelforschung 47 (1997) 1116-1124
20. Laitinen K.S., Tuomisto L., and Laitinen J.T. Endogenous serotonin modulates histamine release in the rat hypothalamus as measured by in vivo microdialysis. Eur J Pharmacol 285 (1995) 159-164
21. 1 receptor agonists in the mouse forced swim test. Br J Pharmacol 123 (1998) 1331-1336
22. Lidbrink P., Jonsson G., and Fuxe K. The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. Neuropharmacology 10 (1971) 521-536
23. Lin J.S., Hou Y., Sakai K., and Jouvet M. Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J Neurosci 16 (1996) 1523-1537
24. Lin E.H., Katon W., Von Korff M., Rutter C., Simon G.E., Oliver M., et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 27 (2004) 2154-2160
25. Magarinos A.M., and McEwen B.S. Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc Natl Acad Sci U S A 97 (2000) 11056-11061
26. 3) visualized in the brain of human and non-human primates. Brain Res 526 (1990) 322-327
27. Mazurkiewicz-Kwilecki I.M. Single and repeated air blast stress and brain histamine. Pharmacol Biochem Behav 12 (1980) 35-39
28. McCall A.L. The impact of diabetes on the CNS. Diabetes 41 (1992) 557-570
29. 1A receptor in the mouse tail suspension test. Neuropsychopharmacology 29 (2004) 461-469
30. 1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene. Br J Pharmacol 104 (1991) 270-276
31. Nishibori M., Oishi R., Itoh Y., and Saeki K. Changes in histamine metabolism in the brains of mice with streptozotocin-induced diabetes. J Neurochem 52 (1989) 1375-1381
32. Noguchi S., Fukuda Y., and Inukai T. Possible contributory role of the central histaminergic system in the forced swimming model. Arzneimittelforschung 42 (1992) 611-613
33. Ohtani N., Ohta M., and Sugano T. Microdialysis study of modification of hypothalamic neurotransmitters in streptozotocin-diabetic rats. J Neurochem 69 (1997) 1622-1628
34. Onodera K. Muricidal suppression by chlorpheniramine and changes in brain levels following dietary-induced thiamine deficiency in rats. Physiol Behav 41 (1987) 71-78
35. Onodera K., Yamatodani A., Watanabe T., and Wada H. Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog Neurobiol 42 (1994) 685-702
36. Prast H., Heistracher M., and Philippu A. In vivo modulation of the histamine release in the hypothalamus by adrenoreceptor agonists and antagonists. Naunyn-Schmiedebergs Arch Pharmacol 344 (1991) 183-186
37. Prast H., Heistracher M., and Philippu A. Modulation by dopamine receptors of the histamine release in the rat hypothalamus. Naunyn-Schmiedebergs Arch Pharmacol 347 (1993) 301-305
38. Schein P.S. 1-Methyl-1-nitrosourea depression of brain nicotinamide adenine dinucleotide in the production of neurologic toxicity. Proc Soc Exp Biol Med 131 (1969) 517-520
39. Schwartz J.C., Arrang J.M., Garbarg M., Pollard H., and Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev 71 (1991) 1-51
40. Shimizu H. Alteration in hypothalamic monoamine metabolism of freely moving diabetic rat. Neurosci Lett 131 (1991) 225-227
41. 1-receptor antagonists on monoamine metabolism in the mouse brain. Naunyn-Schmiedebergs Arch Pharmacol 343 (1991) 185-189
42. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85 (1985) 367-370
43. 1-antagonist-induced place preference in rats. Jpn J Pharmacol 81 (1999) 332-338
44. Tarui S., Yamada K., and Hanafusa T. Animal models utilized in the research of diabetes mellitus-with special reference to insulitis-associated diabetes. Prog Clin Biol Res 229 (1987) 211-223
45. Tatsumi M., Groshan K., Blakely R.D., and Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340 (1997) 249-258
46. 3H] mepyramine. Proc Natl Acad Sci U S A 75 (1978) 6290-6294
47. Watanabe T., Taguchi Y., Shiosaka S., Tanaka J., Kubota H., Terano Y., et al. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 295 (1984) 13-25
48. 3 autoreceptors during handling stress in the prefrontal cortex of the rat. Synapse 43 (2002) 238-243
49. 11C]doxepin and positron emission tomography. Neurosci Lett 137 (1992) 145-148
50. 1 receptors in mice: behavioral and neurochemical characterization. Life Sci 62 (1998) 1607-1610
51. 1 receptors. Neuroscience 87 (1998) 479-487
52. Yoshitomi I., Itoh Y., Oishi R., and Saeki K. Brain histamine turnover enhanced by footshock. Brain Res 362 (1986) 195-198
53. Yoshitomi I., Oishi R., and Saeki K. Involvement of opioid and non-opioid mechanisms in footshock-induced enhancement of brain histamine turnover in mice. Brain Res 398 (1986) 57-62
54. Yuzurihara M., Ikarashi Y., Ishige A., Sasaki H., Kuribara H., and Maruyama Y. Effects of drugs acting as histamine releasers or histamine receptor blockers on an experimental anxiety model in mice. Pharmacol Biochem Behav 67 (2000) 145-150